about
SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUSEntirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune ResponsesMasquerading microbial pathogens: capsular polysaccharides mimic host-tissue moleculesPneumococcal Capsules and Their Types: Past, Present, and FutureGlycotherapy: new advances inspire a reemergence of glycans in medicineGlycan microarrays for decoding the glycome.Parasite Carbohydrate Vaccines.Glyco-epitope Diversity: An Evolving Area of Glycomics Research and Biomarker Discovery.How Heidelberger and Avery sweetened immunology.History of passive antibody administration for prevention and treatment of infectious diseases.Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunityCapsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.Carbohydrate vaccines as immunotherapy for cancer.Carbohydrate based vaccines.Staphylococcus aureus vaccines: Deviating from the carolPathogenesis of Staphylococcus aureus Bloodstream Infections.Carbohydrate vaccines: developing sweet solutions to sticky situations?The 10(th) Anniversary of Carbohydrate Microarrays (2002-2012)Progress in understanding the assembly process of bacterial O-antigen.Implications of plant glycans in the development of innovative vaccines.E. coli Group 1 Capsular Polysaccharide Exportation Nanomachinary as a Plausible Antivirulence Target in the Perspective of Emerging Antimicrobial Resistance.Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale.THE IDENTITY OF THE MECHANISMS OF TYPE-SPECIFIC AGGLUTININ AND PRECIPITIN REACTIONS WITH PNEUMOCOCCUS.THE IMMUNOLOGICAL RELATIONSHIPS OF STREPTOCOCCUS VIRIDANS AND CERTAIN OF ITS CHEMICAL FRACTIONS : I. SEROLOGICAL REACTIONS OBTAINED WITH ANTIBACTERIAL SERA.A STUDY ON BACTERIAL PROTEINS WITH SPECIAL CONSIDERATION OF GONOCOCCUS AND MENINGOCOCCUS.IMMUNOLOGICAL STUDIES ON A NEW PREPARATION OF TYPE SPECIFIC POLYSACCHARIDE FROM PNEUMOCOCCUS TYPE I.CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDE.STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VI. THE SPECIFIC EFFECT OF PNEUMOCOCCUS SOLUBLE SUBSTANCE ON THE GROWTH OF PNEUMOCOCCI IN NORMAL SERUM-LEUCOCYTE MIXTURES.THE ANTIBODY-FORMATION BY POLYSACCHARIDS.IMMUNOLOGICAL RELATIONSHIPS OF CELL CONSTITUENTS OF PNEUMOCOCCUS.A SPECIFIC FLOCCULATION REACTION OCCURRING BETWEEN ALCOHOLIC EXTRACTS OF PNEUMOCOCCI AND ANTIPNEUMOCOCCUS SERUM.THE IMMUNOLOGICAL RELATIONSHIPS OF STREPTOCOCCUS VIRIDANS AND CERTAIN OF ITS CHEMICAL FRACTIONS : II. SEROLOGICAL REACTIONS OBTAINED WITH ANTINUCLEOPROTEIN SERA.An Investigation of the Bacilli of the Capsulatusmucosus Group.ON THE NATURE OF BACTERIAL ALLERGIES.A STUDY OF PNEUMOCOCCI ISOLATED FROM HORSES UNDERGOING PNEUMOCOCCUS IMMUNIZATION.CHEMOIMMUNOLOGICAL STUDIES ON THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : I. THE ISOLATION AND PROPERTIES OF THE ACETYL POLYSACCHARIDE OF PNEUMOCOCCUS TYPE I.DEMONSTRATION OF TYPE SPECIFIC PROTEINS IN EXTRACTS OF FUSOBACTERIA.STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : I. ANTIBODY RESPONSE OF RABBITS IMMUNIZED WITH TYPE III PNEUMOCOCCUS.THE CHEMICAL NATURE OF RESIDUE ANTIGEN PREPARED FROM YEAST.THE SIGNIFICANCE OF ANAPHYLAXIS IN PNEUMOCOCCUS IMMUNITY
P2860
Q24684141-40FB6323-A911-4D09-AA49-AA51FEF9646DQ26746887-CD931212-2E6E-4BB2-A456-D36E049B6EA1Q26865784-E18460EF-DFDE-4A35-B063-E284B6D54091Q27006887-E2002D30-D589-4E66-9A70-840A95BE9649Q27027997-885B9489-BCB8-4BA5-B4C7-DFE007EE4051Q31004845-D6B1ED58-73FD-4EAA-966B-A54235D2ED3DQ33785863-34574478-2CAE-4DA2-9AF6-2D1F41F83AE0Q34449556-73F1E37D-8A86-4166-B4E6-7D4A5FD8368FQ34562757-145115B9-F7EC-4E7D-8DE2-C7B45A0AB630Q35624143-299151AB-005F-4FE6-9378-B7C221DD9C60Q35844906-DD6674BF-70B1-45CE-8220-5B157DE76040Q36181172-AF196FC1-4A76-4D25-9FD5-4806D8177B5BQ36201691-C9310C9E-C66A-4CBA-8272-C5EEF30D4D09Q36456178-B7207723-98FA-42A3-B4ED-1A36EED14689Q37197990-989AEC18-0010-473A-A3B3-3600FC8C3340Q37347046-0FD45D03-BF4C-4DFA-934C-CFBF0F928826Q37426039-3771D12C-65DE-4485-889F-67926E412CE0Q37727535-50920D29-1357-427F-8973-1E16588BCF4BQ38195074-3C34ED47-0751-4BBA-8C18-A04F6F2A71B7Q38738762-C05AA20B-5C25-4B8A-8660-41719814A735Q39143538-86E25B31-00D0-4D8B-ADAE-AB831F1955DFQ41629044-2E8CB410-2C99-461B-B84F-CFABF415603CQ41769116-915B2CC4-445A-4317-8BDB-A2617310768AQ41854455-199ADBBB-6B53-4E5E-8416-244C85D1262AQ41893642-51544318-1061-4231-B283-852ABC038C20Q41922686-66C3B538-7302-4356-9421-C9C03B4BA110Q41986576-234CB4EE-8CBC-4F65-AEFE-DFD8198EF160Q42001027-C31D89AD-0DAD-4267-B09D-D8371ECEF3ACQ42036884-28AC0002-01FD-4E81-AC7E-E33FB3FB8E23Q42084891-3078D036-3335-4358-93D7-1F35ED52D9C4Q42091551-9FE2DF76-9BD2-4B6C-9706-17DB59A795D8Q42113322-1EE0EF2C-6C90-4FE1-9449-6FDDF1476445Q42125090-02600441-69DF-43A9-8273-DAE1F7069553Q42126614-83E7E0B1-5C51-48EB-8D73-CE9A21C672D4Q42264207-392E2CD7-D140-4D5C-8B60-A3C10815E922Q42266187-9E8DFC57-3BFD-4FB4-A81B-2038A7B46AE2Q42284963-8F386D06-4334-440C-8079-0C79FE2C5DD3Q42737945-6573C716-A5FF-4EF9-8140-AACFE7478469Q42788004-0D55DF46-8EFB-41E2-B65E-B5E43EA2DD37Q42792082-1A31ED0E-77BB-47EF-928F-C32473187BE6
P2860
description
1923 nî lūn-bûn
@nan
1923年の論文
@ja
1923年論文
@yue
1923年論文
@zh-hant
1923年論文
@zh-hk
1923年論文
@zh-mo
1923年論文
@zh-tw
1923年论文
@wuu
1923年论文
@zh
1923年论文
@zh-cn
name
THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.
@en
type
label
THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.
@en
prefLabel
THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.
@en
P356
P1476
THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.
@en
P2093
Heidelberger M
P2860
P356
10.1084/JEM.38.1.73
P407
P577
1923-06-01T00:00:00Z